Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma.

R Herbrecht
, P Borchmann
, Martin Wilhelm
, F Morschhauser
, G Hess
, K Kutz
, S Comis
, BL Laffranchi
, A Engert

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	682A-683A
Fachzeitschrift	BLOOD
Jahrgang	104
Ausgabenummer	11
Publikationsstatus	Veröffentlicht - 2004
Veranstaltung	46th Annual Meeting of the American-Society-of-Hematology - San Diego, CA Dauer: 4 Dez. 2004 → 7 Dez. 2004

Dieses zitieren

Herbrecht, R., Borchmann, P., Wilhelm, M., Morschhauser, F., Hess, G., Kutz, K., Comis, S., Laffranchi, BL., & Engert, A. (2004). Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma. BLOOD , 104(11), 682A-683A.

Herbrecht, R ; Borchmann, P ; Wilhelm, Martin et al. / Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma. in: BLOOD 2004 ; Jahrgang 104, Nr. 11. S. 682A-683A.

@article{832d5a9052524816a6f6f6abde049af0,

title = "Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma.",

author = "R Herbrecht and P Borchmann and Martin Wilhelm and F Morschhauser and G Hess and K Kutz and S Comis and BL Laffranchi and A Engert",

year = "2004",

language = "English",

volume = "104",

pages = "682A--683A",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

note = "46th Annual Meeting of the American-Society-of-Hematology ; Conference date: 04-12-2004 Through 07-12-2004",

}

Herbrecht, R, Borchmann, P, Wilhelm, M, Morschhauser, F, Hess, G, Kutz, K, Comis, S, Laffranchi, BL & Engert, A 2004, 'Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma.', BLOOD , Jg. 104, Nr. 11, S. 682A-683A.

Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma. / Herbrecht, R; Borchmann, P; Wilhelm, Martin et al.
in: BLOOD , Jahrgang 104, Nr. 11, 2004, S. 682A-683A.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma.

AU - Herbrecht, R

AU - Borchmann, P

AU - Wilhelm, Martin

AU - Morschhauser, F

AU - Hess, G

AU - Kutz, K

AU - Comis, S

AU - Laffranchi, BL

AU - Engert, A

PY - 2004

Y1 - 2004

M3 - Abstract (Journal)

SN - 0006-4971

VL - 104

SP - 682A-683A

JO - BLOOD

JF - BLOOD

IS - 11

T2 - 46th Annual Meeting of the American-Society-of-Hematology

Y2 - 4 December 2004 through 7 December 2004

ER -

Herbrecht R, Borchmann P, Wilhelm M, Morschhauser F, Hess G, Kutz K et al. Preliminary phase II study results of BBR2778 in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkinxxxs lymphoma. BLOOD . 2004;104(11):682A-683A.